Print

Abbott Laboratories (ABT) Profit Falls 40% on Acquisition, Recall Costs  
10/20/2010 8:25:03 AM

Wall Street Journal -- Abbott Laboratories reported a 40% drop in third-quarter earnings, weighed down by costs associated with layoffs, a baby-formula recall and the withdrawal of a diet drug due to safety concerns.
//-->